• SENSEX 76,379.30
    -375.75 (--0.49%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • HDFC Bank
    743.25 726.75(%)
  • CIE Automotive
    411.35 382.20(%)
  • Oracle Fin.Serv.
    9,950.00 6,232.20(%)
  • Bluestone Jewel
    732.05 400.40(%)
  • Bharti Airtel
    1,925.60 1,745.00(%)
  • Bajaj Finance
    1,037.00 788.40(%)
  • Reliance Industries
    1,268.00 1,253.65(%)
  • Bajaj Finserv
    1,900.15 2,194.65(%)
  • Tanla Platforms
    656.70 765.75(%)
  • Maruti Suzuki
    13,371.65 12,202.10(%)
  • Gandhar Oil Ref.
    283.85 245.00(%)
  • Route Mobile
    649.90 949.80(%)
  • Eternal
    296.15 368.40(%)
  • Adani Green
    1,372.70 767.00(%)
  • IndusInd Bank
    999.00 710.85(%)
  • SBI
    1,006.50 786.55(%)
  • Axis Bank
    1,219.05 1,041.30(%)
  • CG Power & Ind
    881.00 525.50(%)
  • Timken India
    3,103.15 3,924.30(%)
  • SBI Funds Mgt.
    575.35 582.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Amanta Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 23748.0
  • ISIN : INE084K01015
167.00 -1 (-0.55%)
  • As on 23 Jul 2026 (EOD)
  • Today’s Low

    165.00
  • Today’s High

    168.00
  • Open

    168.00
  • Perv Close

    167.93
  • 52W Low

    92.00
  • 52W High

    189.00

Key Indicators

  • P/E(TTM)

    39.48

  • Mar.Cap (₹Cr.)

    648.45

  • Div & Yield %

    0.00

  • Book Value(₹)

    56.71

  • Debt-Equity Ratio

    -0.55

  • AGM Date

    22-Jul-2026

  • EPS

    4.23

  • P/E Ratio

    39.48

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    648.45

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    38.83

  • BV (₹)

    56.70

  • Sales( ₹ in Cr.)

    287.68

  • NP (in Cr.)

    16.44

  • NP Var(%)

    55.0

  • Div%

    0.0

  • CPS (₹)

    9.10

  • EPS (₹)

    4.20

  • Traded Value (₹ in Lakhs)

    648.45

  • 52 Week High

    189.00

  • 52 Week Low

    92.00

  • Price BSE

    167.0

  • Price NSE

    167.00

  • Market Capital( in Cr.)

    648.45

  • P/C Ratio

    18.40

  • P/E Ratio

    39.50

  • Price Vs.BV

    4.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 274.71 280.34 259.13 225.44 171.29 184.37
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 274.71 280.34 259.13 225.44 171.29 184.37
Other Income 1.39 1.27 3.57 76.09 1.06 2.13
Stock Adjustments 19.53 -17.31 -0.53 12.29 14.32 3.90
Total Income 295.63 264.30 262.17 313.82 186.67 190.40
EXPENDITURE :            
Raw Materials 76.99 52.82 101.24 89.09 63.84 67.72
Power and Fuel Cost 22.23 24.74 23.36 17.85 14.24 18.36
Employee Cost 36.34 32.55 31.87 39.59 34.43 33.29
Other Manufacturing Expenses 60.36 58.93 36.86 24.20 17.98 17.92
Selling and Administration Expenses 34.52 33.41 9.19 9.99 9.51 8.59
Miscellaneous Expenses 4.12 3.10 3.35 4.96 7.28 5.01
Employee Benefit Expenses 36.34 32.55 31.87 39.59 34.43 33.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 234.56 205.54 205.87 185.68 147.27 150.89
Operating Profit 61.06 58.76 56.31 128.15 39.40 39.50
Interest 27.95 33.64 35.27 48.88 40.13 38.13
Gross Profit 33.11 25.12 21.04 79.27 -0.73 1.37
Depreciation 18.40 19.73 18.35 17.34 17.02 16.49
Profit Before Tax 14.71 5.39 2.69 61.93 -17.75 -15.12
Current Tax 3.59 4.10 -1.28 6.78 3.77 3.53
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.61 -2.35 6.09 0.04 0.31 0.23
Reported Net Profit 10.50 3.63 -2.11 55.11 -21.83 -18.87
Extraordinary Items -0.07 -0.01 0.00 67.84 0.00 0.00
Adjusted Net Profit 10.57 3.64 -2.11 -12.73 -21.83 -18.87
Adjustment below Net Profit -0.40 -0.23 0.00 -2.03 0.00 18.87
P & L Balance brought forward 16.14 10.82 15.00 -40.71 -18.87 -18.87
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -2.33 -1.91 2.06 0.00 0.00 0.00
P & L Balance carried down 28.56 16.14 10.82 12.37 -40.71 -18.87
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.64 1.35 -0.79 20.54 -8.14 -7.04
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 33.43 24.71 23.44 23.25 2.71 10.85
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    63.80%

  • Public Share Holding

    36.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 14,341,571 14,341,571.00 14,341,571 14,341,571
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 14,341,571 36.93 14,341,571 9
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,100,000 7.98 3,100,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,332,289 18.88 7,332,289 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,432,289 26.87 10,432,289 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 168,463 0.43 168,463 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,067,840 5.33 2,067,840 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,948,087 7.59 2,948,087 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,184,390 13.35 5,184,390 12
2] Non Institution
Bodies Corporate 457,184 1.18 457,184 39
Clearing Members 285,127 0.73 285,127 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 431,693 1.11 431,693 62
Foreign Non Institution Other 300,190 0.77 300,190 1
Hindu Undivided Families 462,096 1.19 462,096 310
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,859,507 7.36 2,246,807 50
Individuals holding nominal share capital up to Rs. 1 lakh 3,917,481 10.09 3,636,419 12,111
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,871,101 22.85 7,977,339 12,586
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 38,829,351 100.00 37,910,426 12,612

Company Background

Amanta Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Amanta Healthcare Ltd
  • BSE Code : 23748.0
  • ISIN : INE084K01015
  • Incorporation Year

    1994

  • Registered Office

    8th Floor Shaligram Corporates
    C.J.Marg Ambli, Ahmedabad,
    Gujarat-380058

  • Telephone

    079 6777 7600

  • FAX

  • Chairman

    Bhavesh Patel

  • Managing Director

    Bhavesh Patel

  • Company Secretary

    Nikhita Dinodia

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Amanta Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Amanta Healthcar 167.00 276.09 274.71 43.60 14.77
Abbott India 28,898.60 7,217.19 6,929.05 39.57 43.78
Astrazeneca Phar 8,033.05 2,304.07 2,275.58 107.09 27.86
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 474.15 450.25 19.27 18.77
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77